PMID- 17027562 OWN - NLM STAT- MEDLINE DCOM- 20061124 LR - 20131121 IS - 0002-9149 (Print) IS - 0002-9149 (Linking) VI - 98 IP - 8 DP - 2006 Oct 15 TI - Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. PG - 1012-7 AB - Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 +/- 1.2 vs 5.3 +/- 1.3 vs 4.6 +/- 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 +/- 2.2 vs 23.3 +/- 2.1 vs 27.9 +/- 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome. FAU - Liu, Ping-Yen AU - Liu PY AD - Division of Cardiology, Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. FAU - Li, Yi-Heng AU - Li YH FAU - Chan, Shih-Hung AU - Chan SH FAU - Lin, Li-Jen AU - Lin LJ FAU - Wu, Hua-Lin AU - Wu HL FAU - Shi, Guey-Yueh AU - Shi GY FAU - Chen, Jyh-Hong AU - Chen JH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060822 PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 RN - 97C5T2UQ7J (Cholesterol) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Acute Disease MH - Case-Control Studies MH - Cholesterol/blood MH - Cohort Studies MH - Coronary Disease/*etiology/*genetics MH - Diabetes Complications MH - Female MH - Genetic Predisposition to Disease/*genetics MH - Genotype MH - Humans MH - Hypertension/complications MH - Male MH - Matrix Metalloproteinase 3/blood/*genetics MH - Middle Aged MH - Phenotype MH - *Polymorphism, Single Nucleotide MH - Risk Factors MH - Smoking/*adverse effects EDAT- 2006/10/10 09:00 MHDA- 2006/12/09 09:00 CRDT- 2006/10/10 09:00 PHST- 2006/02/15 00:00 [received] PHST- 2006/05/01 00:00 [revised] PHST- 2006/05/01 00:00 [accepted] PHST- 2006/10/10 09:00 [pubmed] PHST- 2006/12/09 09:00 [medline] PHST- 2006/10/10 09:00 [entrez] AID - S0002-9149(06)01273-2 [pii] AID - 10.1016/j.amjcard.2006.05.017 [doi] PST - ppublish SO - Am J Cardiol. 2006 Oct 15;98(8):1012-7. doi: 10.1016/j.amjcard.2006.05.017. Epub 2006 Aug 22.